Markus Schwertfeger
Impact in
- Biochemistry top 10%
- Amino Acid Enzymes and Metabolism
-
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
Papers in
- Surgery 8
- Lipoproteins and Cardiovascular Health 4
- Peripheral Artery Disease Management 4
-
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Christian Fleck (3 shared papers)E. Karge (2 shared papers)Frank Schweitzer (2 shared papers)Alexander Janz (2 shared papers)David Pittrow (5 shared papers)Ch. Fleck (4 shared papers)Joachim Röther (2 shared papers)Klaus G. Parhofer (2 shared papers)
- Journals
- Amino Acids (4 papers)Value in Health (3 papers)European Heart Journal (2 papers)Kidney International (2 papers)Atherosclerosis (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Markus Schwertfeger
22 papers receiving 400 citations
Peers
Comparison fields: 5 of 56
- Biochemistry 42
- Cardiology and Cardiovascular Medicine 97
- Internal Medicine 13
- Clinical Biochemistry 27
- Surgery 155
Countries citing papers authored by Markus Schwertfeger
This map shows the geographic impact of Markus Schwertfeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Schwertfeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Schwertfeger more than expected).
Fields of papers citing papers by Markus Schwertfeger
This network shows the impact of papers produced by Markus Schwertfeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Schwertfeger. The network helps show where Markus Schwertfeger may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Schwertfeger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 93 | |
| 2 | 2010 | 78 | |
| 3 | 2009 | 58 | |
| 4 | 2001 | 51 | |
| 5 | 2023 | 37 | |
| 6 | 2003 | 22 | |
| 7 | 2010 | 13 | |
| 8 | 2003 | 10 | |
| 9 | 1997 | 8 | |
| 10 | 2025 | 6 | |
| 11 | 2010 | 5 | |
| 12 | 2000 | 5 | |
| 13 | 2009 | 5 | |
| 14 | 2003 | 4 | |
| 15 | 2009 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2014 | 2 | |
| 18 | 2014 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About Markus Schwertfeger
Markus Schwertfeger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Economics and Econometrics, Biochemistry and Pulmonary and Respiratory Medicine, having authored 23 papers that have together received 408 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Peripheral Artery Disease Management (4 papers), Metabolism and Genetic Disorders (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Biomedical Research and Pathophysiology (2 papers) and Nitric Oxide and Endothelin Effects (2 papers). The work is most often cited by research in Biochemistry (42 citations), Cardiology and Cardiovascular Medicine (97 citations), Internal Medicine (13 citations), Clinical Biochemistry (27 citations) and Surgery (155 citations). Markus Schwertfeger has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Christian Fleck, E. Karge, Frank Schweitzer, Alexander Janz, David Pittrow, Ch. Fleck, Joachim Röther, Klaus G. Parhofer, Uwe Zeymer and Christiane Binz. Their work appears in journals such as Amino Acids, Value in Health, European Heart Journal, Kidney International and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.